| Jennifer L Chivers, SLP | |
|
1501 Thompson St, Bloomer, WI 54724-1257 | |
| (715) 568-2000 | |
| Not Available |
| Full Name | Jennifer L Chivers |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 1501 Thompson St, Bloomer, Wisconsin |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497082713 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 2077 (Wisconsin) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jennifer L Chivers, SLP Po Box 1510, Eau Claire, WI 54702-1510 Ph: (715) 838-3635 | Jennifer L Chivers, SLP 1501 Thompson St, Bloomer, WI 54724-1257 Ph: (715) 568-2000 |
News Archive
Medical professionals all want to be able to quickly and correctly diagnose diseases. Their future ability to do so will depend on identifying what biochemicals are present in tissue sections, where the biomolecules are, and at what concentrations.
There's around 95 to 100 simulation centres across the NHS in secondary care. These centres are used for a whole variety of training, practicing of skills and recreating incidents so that staff can prevent them recurring.
Boehringer Ingelheim Pharmaceuticals, Inc., today announced that the U.S. Food and Drug Administration (FDA) has approved Mirapex ER® (pramipexole dihydrochloride) extended-release tablets, a new once-daily treatment option for the signs and symptoms of early idiopathic Parkinson's disease (PD). MIRAPEX ER is not indicated in advanced PD. Parkinson's disease is a chronic, slowly progressive and potentially debilitating neurological condition affecting nearly one million people in the U.S., with one person newly diagnosed every nine minutes.
Biologic disease-modifying antirheumatic drugs (DMARDs) such as adalimumab, etanercept and infliximab are effective at reducing symptoms and slowing progression of rheumatoid arthritis (RA). These drugs act more quickly, require less laboratory monitoring, and are better tolerated than nonbiologic DMARDs, but they are also up to 100 times more expensive.
› Verified 4 days ago
Tania Riske, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1501 Thompson St, Bloomer, WI 54724 Phone: 715-568-4650 | |
Autumn Schlichting, Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 1501 Thompson St, Bloomer, WI 54724 Phone: 715-838-5222 | |
Mrs. Darcy Lynette Vrieze, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1501 Thompson St, Bloomer, WI 54724 Phone: 715-838-5222 | |
Jeremy Trautlein, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1731 17th Ave, Bloomer, WI 54724 Phone: 715-568-4669 Fax: 715-568-4673 | |
Janelle Hutter, MSLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 1731 17th Ave, Bloomer, WI 54724 Phone: 715-568-4669 Fax: 715-568-4673 | |
Nancy Deboe, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1402 Main St, Bloomer, WI 54724 Phone: 715-568-4669 |